Published in Proc Natl Acad Sci U S A on February 27, 2001
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect (2003) 2.98
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet (2003) 2.88
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species. Mol Cell Biol (2009) 2.27
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell (2011) 2.12
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet (2010) 2.06
Inborn and acquired metabolic defects in cancer. J Mol Med (Berl) (2011) 2.06
Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. Am J Hum Genet (2008) 1.96
Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2005) 1.85
Molecular diagnosis and therapy of kidney cancer. Annu Rev Med (2010) 1.82
Oncometabolites: linking altered metabolism with cancer. J Clin Invest (2013) 1.78
Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer (2004) 1.65
Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet (2005) 1.61
Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol (2010) 1.61
A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol (2006) 1.60
Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res (2012) 1.49
Familial cutaneous leiomyomatosis is a two-hit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol (2001) 1.46
Disruption of tubular Flcn expression as a mouse model for renal tumor induction. Kidney Int (2015) 1.46
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol (2004) 1.37
Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer. Clin Cancer Res (2013) 1.34
Epidemiology of myomas. Obstet Gynecol Clin North Am (2006) 1.33
Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism. Hum Mol Genet (2010) 1.33
Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer (2009) 1.32
Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer (2011) 1.30
HIF and fumarate hydratase in renal cancer. Br J Cancer (2007) 1.27
TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State. Int J Cell Biol (2012) 1.17
African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol (2012) 1.14
Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. PLoS One (2013) 1.12
The metabolic basis of kidney cancer. Semin Cancer Biol (2012) 1.09
Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn (2005) 1.07
Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet (2006) 1.07
Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome. Am J Surg Pathol (2013) 1.04
The clinical implications of the genetics of renal cell carcinoma. Urol Oncol (2009) 1.03
Comparative proteomic approach identifies PKM2 and cofilin-1 as potential diagnostic, prognostic and therapeutic targets for pulmonary adenocarcinoma. PLoS One (2011) 1.03
Targeted therapies for non-clear renal cell carcinoma. Target Oncol (2010) 1.02
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol (2014) 1.01
Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases. Dev Disabil Res Rev (2010) 1.00
Hereditary leiomyomatosis and renal cell carcinoma. Int J Nephrol Renovasc Dis (2014) 0.99
Familial adult renal neoplasia. J Med Genet (2002) 0.99
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease. Clin Cancer Res (2015) 0.98
Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion. PLoS One (2011) 0.97
Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet (2009) 0.97
A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer. Cancer Genet (2012) 0.96
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther (2008) 0.96
Targeting the Met signaling pathway in renal cancer. Expert Rev Anticancer Ther (2009) 0.96
Nephron-sparing surgery for multifocal and hereditary renal tumors. Curr Opin Urol (2014) 0.94
The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update (2013) 0.93
Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol (2008) 0.93
Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome. Fam Cancer (2012) 0.93
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Oncotarget (2015) 0.93
A rapid and simple procedure for the establishment of human normal and cancer renal primary cell cultures from surgical specimens. PLoS One (2011) 0.92
Understanding the natural biology of kidney cancer: implications for targeted cancer therapy. Rev Urol (2007) 0.90
Aerobic glycolysis: a novel target in kidney cancer. Expert Rev Anticancer Ther (2013) 0.89
Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches. Semin Oncol (2013) 0.89
MED12 exon 2 mutations in histopathological uterine leiomyoma variants. Eur J Hum Genet (2013) 0.87
Reed's Syndrome. Indian J Dermatol (2012) 0.87
Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep (2011) 0.87
Multiple cutaneous and uterine leiomyomatosis syndrome: a review. J Clin Aesthet Dermatol (2013) 0.87
Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Am J Surg Pathol (2016) 0.86
Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry. Mod Pathol (2013) 0.85
Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. Am J Hum Genet (2015) 0.85
10 rare tumors that warrant a genetics referral. Fam Cancer (2013) 0.84
Rare and unusual endocrine cancer syndromes with mutated genes. Semin Oncol (2010) 0.84
Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors. Chin J Cancer (2012) 0.84
Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clin Obstet Gynecol (2016) 0.83
Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol (2009) 0.83
Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas. BMC Res Notes (2014) 0.83
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC): a rapid autopsy report of metastatic renal cell carcinoma. Am J Surg Pathol (2014) 0.83
Renal cell carcinoma: Evolving and emerging subtypes. World J Clin Cases (2013) 0.83
Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis (2014) 0.82
Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Int J Mol Sci (2012) 0.81
Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth. Hum Reprod Update (2015) 0.80
Precision medicine from the renal cancer genome. Nat Rev Nephrol (2016) 0.80
Bioinformatics analysis and expression study of fumarate hydratase in lung cancer. Thorac Cancer (2014) 0.79
Cloning and Initial Functional Characterization of Mlk4α and Mlk4β. Genomics Insights (2011) 0.79
Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer. J Urol (2012) 0.79
Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC). Fam Cancer (2014) 0.78
Current understanding of the molecular mechanisms of kidney cancer: a primer for urologists. Can Urol Assoc J (2007) 0.78
Hereditary papillary renal cell carcinoma primarily diagnosed in a cervical lymph node: a case report of a 30-year-old woman with multiple metastases. BMC Urol (2013) 0.78
Tumour and patient factors in renal cell carcinoma-towards personalized therapy. Nat Rev Urol (2015) 0.78
A critical assessment of morcellation and its impact on gynecologic surgery and the limitations of the existing literature. Am J Obstet Gynecol (2015) 0.78
Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood) (2016) 0.77
Activating transcription factor 3 gene expression suggests that tissue stress plays a role in leiomyoma development. Fertil Steril (2008) 0.77
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression. Oncotarget (2015) 0.77
Fine mapping of the uterine leiomyoma locus on 1q43 close to a lncRNA in the RGS7-FH interval. Endocr Relat Cancer (2015) 0.77
Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations. World J Urol (2014) 0.76
Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol (2011) 0.76
Mitochondrial dysfunction and risk of cancer. Br J Cancer (2015) 0.76
Genetic counseling in renal masses. Adv Urol (2008) 0.75
Genetic predisposition to kidney cancer. Semin Oncol (2016) 0.75
Familial syndromes coupling with small renal masses. Adv Urol (2008) 0.75
A rare presentation of acute heart failure secondary to aggressive uterine leiomyosarcoma metastatic to the myocardium initially diagnosed as hypertrophic obstructive cardiomyopathy. Ann Transl Med (2016) 0.75
Fibroids: Genotype and Phenotype. Clin Obstet Gynecol (2016) 0.75
Immunohistochemical Characterization of Fumarate Hydratase (FH) and Succinate Dehydrogenase (SDH) in Cutaneous Leiomyomas for Detection of Familial Cancer Syndromes. Am J Surg Pathol (2017) 0.75
Successful treatment of multiple cutaneous leiomyomas with carbon dioxide laser ablation. Postepy Dermatol Alergol (2015) 0.75
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions. J Exp Med (2017) 0.75
A Case of Hereditary Leiomyomatosis and Renal Cell Carcinoma. Case Rep Dermatol Med (2016) 0.75
Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases. Am J Surg Pathol (2016) 0.75
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas. Br J Cancer (2016) 0.75
Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
Faster sequential genetic linkage computations. Am J Hum Genet (1993) 18.83
Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (1993) 11.95
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol (1997) 2.54
Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab (2000) 2.52
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci U S A (1994) 2.38
A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet (1995) 2.25
Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol (1973) 2.12
Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol (1999) 1.84
Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol (1995) 1.52
Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol (1999) 1.52
Contemporary approach to the classification of renal epithelial tumors. Semin Oncol (2000) 1.48
Hereditary nonpolyposis colorectal cancer. Semin Surg Oncol (2000) 1.15
Inherited carcinomas of the kidney. Adv Cancer Res (1998) 1.06
Familial non-VHL non-papillary clear-cell renal cancer. Lancet (1997) 1.05
Genetic and clinical aspects of familial renal neoplasms. Semin Oncol (2000) 0.98
TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer. Prog Exp Tumor Res (1999) 0.94
A program using loss-of-constitutional-heterozygosity data to ascertain the location of predisposing genes in cancer families. Hum Hered (1996) 0.93
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49
Raman spectrum of graphene and graphene layers. Phys Rev Lett (2006) 16.04
Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland. Nat Genet (1992) 15.62
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 9.93
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science (1998) 7.08
Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73
In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet (1995) 6.60
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med (2001) 6.33
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (2001) 6.23
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer (1994) 5.52
The structure of suspended graphene sheets. Nature (2007) 5.51
Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med (1994) 5.12
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol (1994) 4.89
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet (1997) 4.27
Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer (1998) 4.22
Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12
Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med (1997) 4.11
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 4.02
Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol (2005) 4.00
Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol (2000) 3.98
Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (1995) 3.45
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res (1997) 3.37
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
Aggressiveness of screen-detected breast cancers. Lancet (1995) 3.07
A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet (1981) 3.04
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy. Gastroenterology (2000) 3.01
Nanosecond time-dependent fluorescence depolarization of diphenylhexatriene in dimyristoyllecithin vesicles and the determination of "microviscosity". J Biol Chem (1977) 2.97
Genes and languages in Europe: an analysis of mitochondrial lineages. Genome Res (1995) 2.93
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89
Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer (1995) 2.85
Diagnosis of twin zygosity by mailed questionnaire. Hum Hered (1978) 2.85
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. J Clin Oncol (1996) 2.83
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci U S A (1998) 2.80
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell (1999) 2.71
The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae. J Cell Biol (1995) 2.69
Survival of cancer patients in Finland 1955-1994. Acta Oncol (1999) 2.67
Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology (1996) 2.60
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. Hum Mol Genet (1993) 2.46
Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma. Am J Psychiatry (1996) 2.43
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol (2000) 2.41
Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ (1997) 2.41
A digital atlas of breast histopathology: an application of web based virtual microscopy. J Clin Pathol (2004) 2.40
Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med (1995) 2.40
Pericentric inversions of human chromosomes 9 and 10. Am J Hum Genet (1974) 2.40
Survival and neurodevelopmental morbidity at 1 year of age following extremely preterm delivery over a 20-year period: a single centre cohort study. Acta Paediatr (2008) 2.38
Social class as a prognostic factor in breast cancer survival. Cancer (1990) 2.37
An assay for intercellular adhesive specificity. J Cell Biol (1971) 2.35
Evidence for cell-surface glycosyltransferases. Their potential role in cellular recognition. J Cell Biol (1971) 2.29
Risk of cancer in Finnish children living close to power lines. BMJ (1993) 2.29
Optical second-harmonic scattering in rat-tail tendon. Biopolymers (1981) 2.26
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology (2000) 2.25
Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Genes Chromosomes Cancer (2000) 2.24
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
The hydrolethalus syndrome: delineation of a "new", lethal malformation syndrome based on 28 patients. Clin Genet (1981) 2.15
Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut (2005) 2.13
Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res (2001) 2.12
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10
Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. J Clin Oncol (1992) 2.10
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet (1994) 2.08
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol (2000) 2.07
From cross-tabulations to multipurpose exposure information systems: a new job-exposure matrix. Am J Ind Med (1998) 2.07
Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut (2005) 2.07
Hopelessness and risk of mortality and incidence of myocardial infarction and cancer. Psychosom Med (1997) 2.06
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res (1997) 2.03
Progression of asbestosis predicts lung cancer. Chest (1998) 2.02
The membrane concentrations of neutral and positive anesthetics (alcohols, chlorpromazine, morphine) fit the Meyer-Overton rule of anesthesia; negative narcotics do not. Biochim Biophys Acta (1972) 2.02
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol (2000) 2.01
Approach, avoidance, and coping with stress. Am Psychol (1986) 1.97
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst (1996) 1.93
Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res (2001) 1.93
Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res (1996) 1.89
Studies on intercellular adhesive selectivity. Dev Biol (1968) 1.89
Multiple cancer--an epidemiologic exercise in Finland. J Natl Cancer Inst (1985) 1.87
Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect (1999) 1.84
Work-related cancer in the Nordic countries. Scand J Work Environ Health (1999) 1.84
Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol (1999) 1.84
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer (1997) 1.83
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol (1999) 1.83
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene (2000) 1.83